(Q37406014)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19259670%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

review article

1 reference

title

Tumour antigen-targeted immunotherapy for chronic myeloid leukaemia: is it still viable? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19259670%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19259670%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

Catherine L Riley

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19259670%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Morgan G Mathieu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19259670%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Richard E Clark

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19259670%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Robert C Rees

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19259670%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

4 March 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19259670%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

22 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19259670%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

volume

58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19259670%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19259670%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

1489-1499

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19259670%20AND%20SRC:MED&resulttype=core&format=json

Effect of a p210 multipeptide vaccine associated with imatinib or interferon in patients with chronic myeloid leukaemia and persistent residual disease: a multicentre observational trial

22 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00262-009-0675-X

Ex vivo characterization of multiepitopic tumor-specific CD8 T cells in patients with chronic myeloid leukemia: implications for vaccine development and adoptive cellular immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-009-0675-X

Advances in the structural biology, design and clinical development of Bcr-Abl kinase inhibitors for the treatment of chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-009-0675-X

Cancer vaccines: progress reveals new complexities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-009-0675-X

Epigenetic regulation of human cancer/testis antigen gene, HAGE, in chronic myeloid leukemia

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.3324/HAEMATOL.10782

Identifiers

DOI

10.1007/S00262-009-0675-X

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19259670%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference